GALAPAGOS NV's ticker is GLPG and the CUSIP is 36315X101. A total of 137 filers reported holding GALAPAGOS NV in Q4 2019. The put-call ratio across all filers is 1.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $127,000 | -24.0% | 3,000 | 0.0% | 0.09% | -28.5% |
Q2 2022 | $167,000 | -72.5% | 3,000 | -3.2% | 0.12% | -73.4% |
Q1 2020 | $607,000 | +284.2% | 3,100 | +303.6% | 0.46% | +842.9% |
Q4 2019 | $158,000 | +45.0% | 768 | +6.7% | 0.05% | +48.5% |
Q3 2019 | $109,000 | -76.2% | 720 | -85.6% | 0.03% | -79.4% |
Q4 2018 | $458,000 | – | 5,000 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 250,680 | $13,188,000 | 7.26% |
Stonepine Capital Management, LLC | 244,205 | $12,848,000 | 5.85% |
Sio Capital Management, LLC | 224,719 | $11,822,000 | 3.77% |
EcoR1 Capital, LLC | 1,558,749 | $82,006,000 | 2.85% |
BVF INC/IL | 1,119,733 | $58,909,000 | 2.30% |
683 Capital Management, LLC | 701,421 | $36,902,000 | 1.44% |
DAFNA Capital Management LLC | 77,675 | $4,086,000 | 1.08% |
Soleus Capital Management, L.P. | 115,300 | $6,066,000 | 0.94% |
APOGEM CAPITAL LLC | 19,267 | $1,014,000 | 0.64% |
Orbimed Advisors | 723,457 | $38,061,000 | 0.42% |